A cloud-based platform for analyzing cancer data from blood samples.
Official title: NCI SBIR Contract Topic 428 Phase II (Solicitation Number: BAA 75N91022R00027): Cloud-based Liquid-biopsy and Radiomics Platform for the Cancer Research Data Commons
Funded at Earlydiagnostics, INC. · NIH-10906504 · Data updated 2026-11-12
This study is creating a user-friendly online platform that combines blood test results with a lot of cancer research information to help find and treat cancer better, and patients can help by sharing their blood samples for this important work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Earlydiagnostics, INC. NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | August 15, 2023 |
| Project end | August 14, 2025 |
| Funding year | 2023 |
| Award (this year) | $1,994,911 |
| NIH project number | 75N91023C00022-0-9999-1 |
| Project ID | NIH-10906504 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals undergoing cancer treatment or those at high risk for developing cancer who are willing to provide blood samples.
✕Less likely to help
Patients with non-cancerous conditions or those who are not willing to participate in blood sample collection may not benefit from this research.
What this research studies
This research focuses on developing a cloud-computing platform that integrates liquid biopsy data with extensive cancer research datasets. By analyzing genomic and epigenomic profiles from blood samples, the platform aims to enhance cancer detection and treatment strategies. The project will finalize a prototype that combines multi-omics and imaging data, utilizing advanced deep learning tools for comprehensive analysis. Patients can contribute their blood samples, which will be analyzed alongside large datasets to improve personalized cancer care.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and non-invasive methods for cancer detection and treatment.
How similar studies have gone: Previous research has shown promising results in using liquid biopsies and multi-omics analysis for cancer detection, indicating a strong potential for success in this approach.
Where this research is happening
-
Earlydiagnostics, INC.
Los Angeles, United States Active
Researchers
- Principal investigator: Liu, Chun-Chi (Jim) — Earlydiagnostics, INC.
- Study coordinator: Liu, Chun-Chi (Jim)
Related research
Other NIH-funded projects on the same topics.
-
Towards a blood-based test using nanophotonic exosomes to screen and diagnose liver cancer
A new blood test using tiny particles shed by liver cancer cells aims to screen for hepatocellular carcinoma earlier and more accurately.
-
Liquid biopsy test to screen for lymphoma in people with HIV
A new blood test called High Density Methyl-Seq is being checked to see if it can detect lymphoma early in people living with HIV.
-
Liquid biopsy and oxygen therapy to guide glioblastoma treatment
A patient-focused study exploring a blood-based test and a safe oxygen therapy to help doctors tell true tumor growth from treatment effects in adults with glioblastoma treated with chemoradiation.
-
Liquid biopsy to monitor LMS treatment and resistance
A patient-centered look at using blood tests to see how well LMS treatment is working and when resistance to therapy appears.
-
Imagnostix: a simple blood-based test to flag Alzheimer’s risk
A new blood-based test called Imagnostix aims to help identify people who may be developing Alzheimer’s disease earlier and more cheaply than current methods.
-
Multi-omic liquid biopsy to guide immunotherapy in colorectal and anal cancers
A patient-facing overview of a study testing blood-based biomarkers (ctDNA and extracellular RNA) to better tailor immunotherapy for colorectal and anal cancer patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.